532 related articles for article (PubMed ID: 17578899)
1. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
Routaboul C; Norez C; Melin P; Molina MC; Boucherle B; Bossard F; Noel S; Robert R; Gauthier C; Becq F; Décout JL
J Pharmacol Exp Ther; 2007 Sep; 322(3):1023-35. PubMed ID: 17578899
[TBL] [Abstract][Full Text] [Related]
2. Discovery of pyrrolo[2,3-b]pyrazines derivatives as submicromolar affinity activators of wild type, G551D, and F508del cystic fibrosis transmembrane conductance regulator chloride channels.
Noel S; Faveau C; Norez C; Rogier C; Mettey Y; Becq F
J Pharmacol Exp Ther; 2006 Oct; 319(1):349-59. PubMed ID: 16829626
[TBL] [Abstract][Full Text] [Related]
3. Alpha-aminoazaheterocyclic-methylglyoxal adducts do not inhibit cystic fibrosis transmembrane conductance regulator chloride channel activity.
Sonawane ND; Zegarra-Moran O; Namkung W; Galietta LJ; Verkman AS
J Pharmacol Exp Ther; 2008 May; 325(2):529-35. PubMed ID: 18272811
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition.
Kelly M; Trudel S; Brouillard F; Bouillaud F; Colas J; Nguyen-Khoa T; Ollero M; Edelman A; Fritsch J
J Pharmacol Exp Ther; 2010 Apr; 333(1):60-9. PubMed ID: 20051483
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel water-soluble activator of wild-type and F508del CFTR: GPact-11a.
Bertrand J; Boucherle B; Billet A; Melin-Heschel P; Dannhoffer L; Vandebrouck C; Jayle C; Routaboul C; Molina MC; Décout JL; Becq F; Norez C
Eur Respir J; 2010 Aug; 36(2):311-22. PubMed ID: 20110398
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of cystic fibrosis transmembrane conductance regulator (CFTR) Cl- currents by the chemical solvent tetrahydrofuran.
Hughes LK; Ju M; Sheppard DN
Mol Membr Biol; 2008 Sep; 25(6-7):528-38. PubMed ID: 18989824
[TBL] [Abstract][Full Text] [Related]
7. Guanabenz, an alpha2-selective adrenergic agonist, activates Ca2+-dependent chloride currents in cystic fibrosis human airway epithelial cells.
Norez C; Vandebrouck C; Antigny F; Dannhoffer L; Blondel M; Becq F
Eur J Pharmacol; 2008 Sep; 592(1-3):33-40. PubMed ID: 18640110
[TBL] [Abstract][Full Text] [Related]
8. The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein.
Melin P; Thoreau V; Norez C; Bilan F; Kitzis A; Becq F
Biochem Pharmacol; 2004 Jun; 67(12):2187-96. PubMed ID: 15163550
[TBL] [Abstract][Full Text] [Related]
9. Maintaining low Ca2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells.
Norez C; Antigny F; Becq F; Vandebrouck C
Traffic; 2006 May; 7(5):562-73. PubMed ID: 16643279
[TBL] [Abstract][Full Text] [Related]
10. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
Noël S; Wilke M; Bot AG; De Jonge HR; Becq F
J Pharmacol Exp Ther; 2008 Jun; 325(3):1016-23. PubMed ID: 18309088
[TBL] [Abstract][Full Text] [Related]
11. Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by niflumic acid.
Scott-Ward TS; Li H; Schmidt A; Cai Z; Sheppard DN
Mol Membr Biol; 2004; 21(1):27-38. PubMed ID: 14668136
[TBL] [Abstract][Full Text] [Related]
12. General anesthetic octanol and related compounds activate wild-type and delF508 cystic fibrosis chloride channels.
Marcet B; Becq F; Norez C; Delmas P; Verrier B
Br J Pharmacol; 2004 Mar; 141(6):905-14. PubMed ID: 14967738
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels.
Marivingt-Mounir C; Norez C; Dérand R; Bulteau-Pignoux L; Nguyen-Huy D; Viossat B; Morgant G; Becq F; Vierfond JM; Mettey Y
J Med Chem; 2004 Feb; 47(4):962-72. PubMed ID: 14761197
[TBL] [Abstract][Full Text] [Related]
14. Activation of a CFTR-mediated chloride current in a rabbit corneal epithelial cell line.
Al-Nakkash L; Reinach PS
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2364-70. PubMed ID: 11527951
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channel.
Chappe V; Mettey Y; Vierfond JM; Hanrahan JW; Gola M; Verrier B; Becq F
Br J Pharmacol; 1998 Feb; 123(4):683-93. PubMed ID: 9517388
[TBL] [Abstract][Full Text] [Related]
16. Chloride channels in the small intestinal cell line IEC-18.
Basavappa S; Vulapalli SR; Zhang H; Yule D; Coon S; Sundaram U
J Cell Physiol; 2005 Jan; 202(1):21-31. PubMed ID: 15389550
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of cystic fibrosis transmembrane conductance regulator in rat oviduct epithelium.
Chen M; Du J; Jiang W; Zuo W; Wang F; Li M; Chan H; Zhou W
Acta Biochim Biophys Sin (Shanghai); 2008 Oct; 40(10):864-72. PubMed ID: 18850051
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622.
Norez C; Bilan F; Kitzis A; Mettey Y; Becq F
J Pharmacol Exp Ther; 2008 Apr; 325(1):89-99. PubMed ID: 18230692
[TBL] [Abstract][Full Text] [Related]
19. Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect.
Robert R; Carlile GW; Pavel C; Liu N; Anjos SM; Liao J; Luo Y; Zhang D; Thomas DY; Hanrahan JW
Mol Pharmacol; 2008 Feb; 73(2):478-89. PubMed ID: 17975008
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and signaling properties of endogenous P2Y1 receptors in cystic fibrosis transmembrane conductance regulator-expressing Chinese hamster ovary cells.
Marcet B; Chappe V; Delmas P; Verrier B
J Pharmacol Exp Ther; 2004 May; 309(2):533-9. PubMed ID: 14742736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
